The impact of initiation: Early onset marijuana smokers demonstrate altered Stroop performance and brain activation  by Sagar, K.A. et al.
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Marijuana  (MJ)  use is  on  the  rise,  particularly  among  teens  and  emerging  adults.  This  poses  serious  public
health concern,  given  the  potential  deleterious  effects  of  MJ on  the  developing  brain.  We  examined  50
chronic  MJ  smokers  divided  into  early  onset  (regular  MJ use  prior  to  age 16;  n =  24)  and late  onset  (age  16 or
later;  n =  26),  and  34  healthy  control  participants  (HCs).  All  completed  a modiﬁed  Stroop  Color  Word  Test
during fMRI.  Results  demonstrated  that MJ  smokers  exhibited  signiﬁcantly  poorer  performance  on  the
Interference  subtest  of  the  Stroop,  as well  as  altered  patterns  of  activation  in  the  cingulate  cortex  relative
to HCs.  Further,  early  onset  MJ smokers  exhibited  signiﬁcantly  poorer  performance  relative  to  both  HCs
and late  onset  smokers.  Additionally,  earlier  age  of  MJ onset  as  well  as  increased  frequency  and  magnitudege of onset
MRI
xecutive function
ognition
(grams/week)  of MJ use  were predictive  of poorer  Stroop  performance.  fMRI  results  revealed  that  while
late onset  smokers  demonstrated  a more  similar  pattern  of  activation  to the  control  group,  a  different
pattern  was  evident  in  the  early  onset  group.  These  ﬁndings  underscore  the  importance  of  assessing  age
of  onset  and  patterns  of  MJ  use and support  the  need  for widespread  education  and  intervention  efforts
among  youth.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Marijuana (MJ) is predicted to become a multi-billion dollar
ndustry within the next ﬁve years. Currently twenty-three states
nd the District of Columbia have legalized medical MJ,  while four
Colorado, Washington, Oregon, and Alaska) have also approved
ecreational use. As voters say “yes” to MJ,  beneﬁts of use are often
nderscored, while negative effects may  be overshadowed. This
hift in national attitudes is occurring despite mounting evidence
f the deleterious effects of MJ  (Lisdahl et al., 2014; Lubman
t al., 2014), particularly on the developing brain. Although once
onsidered to be complete by early adolescence, longitudinal
tudies demonstrate that the brain continues to develop well into
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adulthood (Casey et al., 2005; Giedd et al., 1999; Gogtay et al., 2004),
leaving adolescents and emerging adults particularly vulnerable
to the potentially adverse effects of MJ  on cognitive processes.
MJ continues to be the most widely used illicit substance and
over the past several years, despite decreasing rates of use for other
substances, rates of MJ  use are climbing among youth (Johnston
et al., 2014; Kann et al., 2014). According to the 2013 Monitoring
the Future survey, more than 36% of 12th graders used MJ  in the
past year, and 6.5% used daily (Johnston et al., 2014). Moreover, sur-
vey data indicate that the perceived risk of MJ  use is approaching
historically low levels; less than half of high school students view
MJ  as harmful. Adolescents who perceive greater risk from MJ  are
less likely to try MJ,  and as a result, the decrease in perception of
harm is directly related to the recent increase in use. This trend
also impacts public safety: the number of teens driving under the
inﬂuence of MJ  has surpassed the number of teens who drive drunk
(Johnston et al., 2014). Youth are also initiating MJ  use at alarmingly
early ages; among those who  began smoking during adolescence,
the average age of onset was  16.3-years old (Substance Abuse and
Mental Health Services Administration, 2013). This poses serious
public health concerns given research ﬁndings demonstrating that
MJ  use is related to cognitive impairments particularly in those
who initiate use during adolescence (Crane et al., 2013; Crean et al.,
2011; Gruber et al., 2012a; Lisdahl et al., 2014; Solowij and Pesa,
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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010), and neuroimaging studies, which highlight the relationship
etween cognitive decrements and alterations in the brain (Batalla
t al., 2013; Gruber et al., 2012b, 2013; Wrege et al., 2014).
Lisdahl et al. (2014) reported that MJ-smoking youth experi-
nce deﬁcits in a variety of cognitive domains, including processing
peed, attention, memory, and executive function. These ﬁnd-
ngs support previous work, which revealed that MJ smokers
xhibit processing deﬁcits during frontally-mediated cognitive
asks, resulting in altered decision-making and behavioral inhi-
ition (Gruber and Yurgelun-Todd, 2005), and that the deﬁcits
bserved in MJ  smokers were primarily attributable to those
ith early MJ  onset (Gruber et al., 2012a). Additionally, Fontes
t al. (2011) reported that early onset MJ  smokers demon-
trated signiﬁcantly worse performance than both controls and late
nset smokers on a neurocognitive battery designed to measure
ustained attention, impulse control, and executive functioning.
euroimaging studies have also revealed a relationship between
ge of MJ  onset and functional alterations (Tapert et al., 2007),
ncluding work demonstrating a differential pattern of brain activa-
ion between early and late onset MJ  smokers on the Multi-Source
nterference Task (MSIT), a measure of inhibitory function (Gruber
t al., 2012b). Several investigations have also reported a relation-
hip between functional alterations and increased MJ  use (Bolla
t al., 2005; Hester et al., 2009; Nestor et al., 2010).
Impulsive personality traits have been identiﬁed as a risk fac-
or and predictor of substance use (Brady et al., 1998; Guy et al.,
994; Heil et al., 2006; Vitaro et al., 1998). Impulsivity is charac-
erized by weak executive control that compromises higher-order
ognitive processes including inhibition, set-shifting, and utiliz-
ng feedback (Wrege et al., 2014). Higher levels of self-reported
mpulsivity, as measured by the Barratt Impulsiveness Scale (BIS),
nd risk taking have been reported in substance abusers (Lejuez
t al., 2002, 2003; Gruber and Yurgelun-Todd, 2005). One study
uggests that MJ  smokers with higher levels of impulsivity held
ewer negative expectancies related to MJ,  and used MJ  more often
han those reporting lower levels of impulsivity (Vangsness et al.,
005). Further, Squeglia and colleagues (2014) found that poorer
erformance on tasks of cognitive inhibition/interference prior
o initiation of substance use during early adolescence predicted
ncreased frequency of MJ  use in late adolescence. In combination
ith the neuroimaging ﬁndings that report alterations in response
nhibition and decision-making (Gruber and Yurgelun-Todd, 2005;
ruber et al., 2012b; Hester et al., 2009; Jacobus et al., 2009;
chweinsburg et al., 2008; Tapert et al., 2007), impulsivity may
eﬂect a stable trait which precedes substance use in MJ  smokers
nd which may  predict increased MJ  use. In addition, recent work
as demonstrated not only that MJ  smokers reported higher levels
f impulsivity than non-MJ smoking individuals, but that within
arly onset MJ  smokers (regular use prior to age 16), higher levels of
mpulsivity were correlated with lower levels of white matter orga-
ization and coherence (Gruber et al., 2013). This suggests that MJ  is
elated to both impulsivity and, particularly in early onset MJ  smok-
rs, alterations of white matter, critical for efﬁcient communication
etween brain regions.
Overall, research has demonstrated that MJ  smokers exhibit
ltered frontal function and suggests that cognitive deﬁcits may
ompromise function, impairing the ability to make good deci-
ions and inhibit inappropriate actions. Given these ﬁndings, we
ypothesized that MJ  smokers would perform more poorly on the
nterference condition of the Stroop Color Word Test and would
xhibit signiﬁcantly different patterns of brain activation relative to
ealthy controls (HC). We  also predicted that performance deﬁcits
n the MJ  smokers would be speciﬁcally related to early onset of MJ
se, and that these performance differences would correspond with
 markedly different pattern of activation than the late onset smok-
rs. Further, we expected that these results would be inﬂuenced byve Neuroscience 16 (2015) 84–92 85
heavier patterns of MJ  use in terms of frequency (smokes/week)
and magnitude (grams/week).
2. Materials and methods
2.1. Participants
Participants were recruited from the Greater Boston Area com-
munity and included 50 chronic, heavy MJ  smokers (age range:
17–46), divided into those with early onset (initiation of regu-
lar MJ  use prior to age 16; n = 24) and late onset (regular MJ use
at age 16 or later; n = 26). Thirty-four non-MJ-smoking, HCs (age
range: 18–48) were also included. Participants were excluded if
they met  criteria for any Diagnostic and Statistical Manual of Men-
tal Disorders (DSM-IV-TR) Axis I pathology (with the exception of
MJ abuse/dependence in the smoking group), as assessed by the
Structured Clinical Interview for DSM-IV, Patient Edition (SCID-P;
First et al., 1994). Individuals were also excluded if they reported
any signiﬁcant head injury with loss of consciousness, history
of a neurological disorder or serious medical problem, previous
and/or current use of psychotropic medications, or were non-
native English speakers. Further, no participant was enrolled if they
reported more than 15 lifetime uses of any illicit drugs (except MJ
for the smoking group) or recreational use of prescription or over-
the-counter (OTC) medications. While a number of participants
had completed other studies which have previously been published
(Gruber et al., 2012a,b), approximately 30% of the participant pool
was newly recruited and had not participated in lab-based clinical
research prior to the current study. Further, cognitive and fMRI data
collected for the current study has not previously been reported.
All MJ  smokers were well-characterized as chronic MJ  smokers.
In order to qualify for study enrollment, MJ smokers had to have
reported smoking a minimum of 2500 times in their lives, used MJ
at least ﬁve out of the last seven days, tested positive for urinary
cannabinoids, and met  DSM-IV criteria for MJ  abuse or dependence.
In addition, in order to ensure that performance on measures of
cognitive tasks was  not impacted by acute intoxication, MJ  smok-
ers were required to abstain from smoking at least 12 h prior to their
study visit. All participants were required to provide a urine sam-
ple upon arrival at the laboratory to assess for the presence of illicit
substances, and in order to ensure adherence to the required 12-h
abstinence, MJ  participants were led to believe that our researchers
could use this sample to detect MJ  use within this time frame, a
method we  have successfully utilized in the past (Gruber et al.,
2011, 2012a,b, 2013). Study participants who reported MJ  use that
violated the abstinence schedule or who  appeared intoxicated were
assessed for recent use and rescheduled for a later date. Individuals
who tested positive for any illicit substance other than MJ were
disqualiﬁed.
MJ use was quantiﬁed using a modiﬁed timeline follow-back
procedure (Sobell et al., 1998). Participants provided information
regarding history of MJ  use, including age of onset, and duration of
use (years), as well as current frequency (smokes/week), magnitude
(grams/week), and mode of use using guided interview questions
(i.e., When did you ﬁrst try MJ? Who  were you with? How did you
use it?), which signiﬁcantly facilitated recall. Lifetime use was also
determined via the SCID-P. As previously mentioned, MJ  smokers
were further divided into two groups based on age of onset of regu-
lar MJ  use in order to determine the potential differential impact of
age of onset on cognitive function. For this study, age of ‘regular’ use
of MJ  was  deﬁned as the age at which subjects began using MJ  on
a routine, expected and consistent basis, and not the age at which
they tried MJ  for the ﬁrst time. Although no uniform deﬁnition of
early and late onset exists, these parameters have been utilized in
several studies (Ehrenreich et al., 1999; Gruber et al., 2011, 2012a,b,
2013; Kempel et al., 2003; Pope et al., 2003).
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Prior to participation, study procedures were thoroughly
xplained, and all participants were required to read and sign an
nformed consent form approved by the McLean Hospital Institu-
ional Review Board. This document describes the procedures, risks,
eneﬁts, and voluntary nature of the study.
.2. Study design
As part of a larger neuroimaging study, participants completed
 modiﬁed version of the Stroop Color Word Test previously used
ith healthy control participants (Gruber et al., 2002) while under-
oing functional magnetic resonance imaging (fMRI) scanning.
rior to scanning, individuals completed a brief practice version of
he task in which they became familiar with the type of task stimuli
s well as the instructions. The Stroop Test contains three subtests:
olor Naming, Word Reading, and Interference. During the Color
aming subtest, individuals are instructed to name the color of
ectangles out loud (vocalized response). The Word Reading sub-
est requires participants to read words printed in black ink, while
he Interference trials consists of words printed in an incongruous
nk color (i.e. the word “green” printed in red ink). Participants are
equired to inhibit the automatic tendency to read the words, and
nstead must name the color of the ink for each word. Each subtest
egins with a period of 30 s of rest in which a ﬁxation point is viewed
n the screen, followed by 30 s of stimuli (6 stimuli per slide), 30 s
xation, a second 30 s period of stimuli, and ends with a ﬁnal 30 s
xation, for a total run time of 2 min  30 s per subtest. Performance
s measured by percent accuracy and error types: commissions
incorrect responses) and omissions (missed responses) for each
ubtest are recorded separately (MacLeod, 1991).
Study participants also completed a battery of assessments
o assess current clinical state and to ensure that groups were
ell matched for different aspects of mood and levels of anxiety.
rieﬂy, these measures included the Proﬁle of Mood States (POMS;
ollock et al., 1979), a measure that reﬂects current mood state
nd provides scores for the individual domains of vigor, anger,
onfusion, tension, and depression, as well as a total mood disturb-
nce score; the Beck Depression Inventory (BDI; Beck et al., 1961);
he State-Trait Anxiety Inventory (STAI; Spielberger et al., 1983);
he Positive and Negative Affect Schedule (PANAS; Watson et al.,
988); the Montgomery-Asberg Depression Rating Scale (MADRS;
ontgomery and Asberg, 1979); the Hamilton Anxiety Scale (HAM-
; Hamilton, 1959); and the Young Mania Rating Scale (YMRS;
oung et al., 1978). The Fagerström Test for Nicotine Dependence
FTND; Heatherton et al., 1991) was also completed by all par-
icipants in order to assess current level of nicotine use, and the
ddiction Severity Index (ASI; McLellan et al., 1980) was adminis-
ered to calculate days of alcohol use within the past month. Finally,
he Barratt Impulsiveness Scale (BIS-11; Patton et al., 1995) was
sed to assess reported levels of impulsivity. This BIS-11 yields
cores for three subscales of impulsivity, attention, motor, and non-
lanning, in addition to a total impulsivity score. All participants
ere administered either the Wechsler Abbreviated Scale of Intel-
igence (WASI) or an abbreviated version of the Wechsler Adults
ntelligence Scale – Revised (WAIS-R), both of which yield an esti-
ate of IQ (Wechsler, 1999, 1981).
.3. Statistical analyses
One-way analyses of variance (ANOVAs) with Scheffé post hoc
omparisons were used to assess between-group differences for
wo different comparisons: two-group (HCs vs all MJ  smokers) and
hree-group (HCs vs early MJ  onset smokers vs late MJ  onset smok-
rs) where age of MJ  onset was used as a categorical variable (early
s late). Univariate logarithmic regression analyses were conducted
o further assess the relationship between MJ  use (age of MJ  onset,ve Neuroscience 16 (2015) 84–92
frequency of MJ  use, and magnitude of MJ  use), and to determine
the extent to which each of these variables predicted performance
on the Stroop task. Logarithmic equations were selected, as they
provided a best ﬁt for the data, and in these analyses, age of onset
was used as a continuous variable.
2.4. Imaging methods
All imaging was  performed on a Siemens Trio whole body 3T
MRI  scanner (Siemens Corporation, Erlangen, Germany) using a
12-channel phased array head coil. Forty contiguous coronal slices
were acquired from each participant, ensuring whole brain cov-
erage (5 mm thick), and images were collected with TR = 3000,
using a single shot, gradient pulse echo sequence (TE = 30 ms, ﬂip
angle = 90, with a 20 cm ﬁeld of view and a 64 × 64 acquisition
matrix; in plane resolution 3.125 mm × 3.125 mm× 3.125 mm). A
total of 50 images per slice were collected in order to ensure com-
parability of tasks with previous studies (Gruber et al., 2002; Gruber
and Yurgelun-Todd, 2005).
2.5. Image processing and analysis
fMRI images were analyzed using SPM8 (version 4290, Well-
come Department of Imaging Neuroscience, University College,
London, UK) software package running in MATLAB (version R2010b,
MathWorks, Natick, MA,  USA). First, blood–oxygen-level depend-
ent fMRI data were corrected for motion in SPM8 using a 2-step
intra-run realignment algorithm that uses the mean image created
after the ﬁrst realignment as a reference. A criterion of 3 mm  of head
motion in any direction was used as an exclusionary criterion. The
realigned images were then normalized to an EPI template in Mon-
treal Neurological Institute (MNI) stereotactic space. Normalized
images were re-sampled into 2 mm cubic voxels and then spatially
smoothed using an isotropic Gaussian kernel with 8 mm full width
at half maximum (FWHM). Global scaling was  not used, high-pass
temporal ﬁltering with a cut-off of 128 s was  applied, and serial
autocorrelations were modeled with an AR(1) model in SPM8.
Statistical parametric images were calculated individually for
each subject for the Interference task using a general linear model.
These images were subsequently entered into second level model,
subjected to a voxel-wise contrast and t-test to assess statistical
signiﬁcance. Direct comparisons between the MJ  smokers and HCs
were made, as well as early vs late smokers. Movement parameters
were included as regressors in the design. The region of interest
(ROI) mask was  created using the Wake Forest University Pick-
atlas utility, and included the cingulate cortex. Contrast analysis
was conducted for the (Interference-rest/ﬁxation)–(Color Naming-
rest/ﬁxation) condition. The statistical threshold was set at 0.0001
uncorrected and a minimum cluster extent (k) of 10 contiguous
voxels.
3. Results
3.1. Demographics, clinical state, and MJ use
Across the study groups, subjects were well-matched for age and
IQ. Chi square analyses of the frequencies of race and gender dis-
tributions indicated no signiﬁcant differences across the HC, early
MJ onset, and late MJ  onset groups. Analyses also revealed no sig-
niﬁcant differences between HCs and MJ  smoking groups for days
of alcohol used, as assessed by the ASI, or nicotine use (FTND). See
Tables 1–2.Comparisons between HCs and MJ  smokers, as well as early and
late onset MJ  smokers also demonstrated that groups were well-
matched for clinical state; no signiﬁcant differences were noted
between the groups for BDI, STAI, POMS, PANAS, HAM-A, YMRS, or
K.A. Sagar et al. / Developmental Cognitive Neuroscience 16 (2015) 84–92 87
Table  1
Healthy controls vs MJ  smokers t-test comparisons.
Variable
Mean (SD)
Healthy controls MJ  smokers Sig 2-tailed
p (2)
N 34 (21 M,  13 F) 50 (42 M,  8 F) –
Handedness 32R, 2L 46R, 4L –
%  Caucasian 67.65% 76.00% –
Age  24.53 (6.57) 23.98 (6.95) NS
Full  Scale IQ (FSIQ) 123.15 (10.94) 117.56 (15.03) NS
Past  month days of alcohol use 5.19 (5.16) 7.25 (5.76) NS
FTNDa 0.00 (0.00) 0.29 (0.86) NS
BIS-11b Sig 1-tailed
p (2)
Attention 14.61 (3.75) 16.65 (2.61) .003 (.096)
Motor 19.58 (4.65) 22.61 (4.55) .003 (.097)
Non-planning 23.19 (4.96) 26.61 (4.61) .002 (.113)
Total  57.39 (10.28) 65.87 (9.40) <.001 (.157)
Stroop Color Word Test Sig 1-tailed
p (2)
Color naming
Percent accuracy 94.28 (5.68) 92.32 (9.25) NS
Omissions 4.53 (5.79) 6.70 (9.98) NS
Commissions 2.09 (2.31) 2.52 (2.38) NS
Word reading
Percent accuracy 99.07 (1.81) 98.17 (2.90) .055 (.031)
Omissions 0.56 (1.31) 0.90 (2.17) NS
Commissions 0.38 (0.82) 1.30 (1.78) .003 (.088)
Interference
Percent accuracy 96.69 (5.33) 92.44 (11.56) .024 (.047)
Omissions 0.79 (1.61) 2.88 (6.08) .027 (.044)
Commissions 1.59 (2.86) 2.48 (3.25) .099 (.020)
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ADRS scores (see Table 3). However, scores on the BIS-11 indi-
ated signiﬁcant differences between HCs and MJ  smokers on all
ubscales (Attention, Motor, and Non-Planning) as well as Total BIS-
1 scores (Table 1), demonstrating higher levels of impulsivity in MJ
mokers. It is of note that while the three-group analyses indicated
hat both the early and late MJ  onset groups differed signiﬁcantly
rom the HC group, no between-group differences for early vs late
J onset were noted for BIS-11 scores (Table 2).
Interestingly, when MJ  smokers were divided into early and
ate onset, the early onset MJ  smokers reported higher frequency
smokes/week; F(1,46) = 5.655, p = .022, 2-tailed) and magnitude
f MJ  use (grams/week; F(1,46) = 6.203, p = .016, 2-tailed). In fact,
he early onset group smoked nearly twice as often and over 2.5
imes as much MJ  as their late onset counterparts (Table 2). It is of
ote, however, that no between-group differences were detected
or duration of MJ  use.
.2. Stroop Color Word Test performance results
Behavioral performance on the Stroop Color Word Test (Table 1)
evealed that MJ  smokers performed signiﬁcantly more poorly rel-
tive to HCs during the Interference condition of the task, despite
chieving similar percent accuracy during the Color Naming and
ord Reading subtests. More speciﬁcally, during the Interference
ondition, MJ  smokers demonstrated signiﬁcantly increased omis-
ion errors (F(1,82) = 3.807, p = .027), or missed responses, and
xhibited a trend for increased commission errors (F(1,82) = 1.678,
 = .099), reﬂective of an inability to inhibit an inappropriate
esponse. Together, these errors yielded lower percent accuracy
cores in MJ  smokers (F(1,82) = 4.016, p = .024) relative to HCs.
Separating the larger MJ  smoking group into those with early
s late MJ  onset revealed that the early onset smokers drove the
etween-group differences noted in task performance (Table 2), asthey performed signiﬁcantly worse relative to both the HCs and
late onset smokers on the Interference subtest. Scheffé post hoc
comparisons indicated that early onset smokers made signiﬁcantly
more errors of omission than both HCs (p = .010) and late onset
smokers (p = .046); early onset smokers also made more errors
of commission than both HCs (p = .037) and late onset smokers
(p = .048). These errors contributed to signiﬁcant differences in per-
cent accuracy between early onset smokers relative to both HCs
(p = .005) and late onset smokers (p = .019) on the Stroop Inter-
ference subtest. Interestingly, no signiﬁcant differences in Stroop
performance were detected between the late onset smokers and
HCs.
In order to further assess the role of these covariates, univari-
ate regression analyses were performed for the variables that were
signiﬁcantly different between the early and late onset groups.
Analyses indicated that earlier age of MJ  onset (Fig. 1) as well as
both higher frequency and increased magnitude of MJ  use each
individually predicted poorer performance on most measures of
the Stroop Interference condition (Table 4). Multivariate modeling
analyses could further dissect the overlap in variance attributable
to these MJ  use variables, but require far larger sample sizes than
the current study provides.
3.3. Stroop Color Word Test: fMRI results
fMRI analyses were conducted on 33 HCs  and 49 MJ  smokers
(24 early onset, 25 late onset), as two subjects (1 HC, 1 late onset
MJ  smoker) had excessive motion and thus were excluded from
imaging analyses. As shown in Table 5, single-group comparisons
of Interference minus Color Naming activation revealed that while
HCs demonstrated robust posterior activation in the right cingulate
cortex, MJ  smokers exhibited more anterior and diffuse activa-
tion throughout the cingulate, including bilateral cingulate regions.
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Table  2
Healthy controls vs early MJ  onset vs late MJ  onset one-way ANOVA results.
Variable
Mean (SD)
Healthy controls Early MJ  onset
(before age 16)
Late MJ  onset (age
16 or after)
Sig 2-tailed
p (2)
Sheffé comparisons sig 2-tailed p
E vs HC L vs HC  E vs L
N 34 (21 M,  13 F) 24 (21 M, 3 F) 26 (21 M,  5 F) – – – –
Handedness 32R, 2L 21R, 3L 25R, 1L – – – –
%  Caucasian 65.00% 73.33% 66.67% – – – –
Age  24.47 (6.49) 23.67 (7.26) 24.27 (6.79) NS NS NS NS
Full  Scale IQ (FSIQ) 123.15 (10.94) 115.38 (17.02) 119.58 (12.93) NS NS NS NS
Past  month days of alcohol use 5.35 (5.56) 5.92 (5.01) 6.06 (6.05) NS NS NS NS
FTNDa 0.00 (0.00) 0.29 (0.91) 0.08 (0.39) NS NS NS NS
MJ  age of onset (years) – 14.17 (1.31) 17.58 (1.94) <.001 (.521) – – –
MJ  smokes/week – 24.51 (21.25) 13.53 (7.74) .022 (.109) – – –
MJ  grams/week – 14.57 (16.97) 5.64 (4.54) .016 (.119) – – –
MJ  duration of use (years) – 9.50 (7.80) 6.69 (5.68) NS – – –
Urinary THC concentration – 784.63 (1430.96) 620.22 (916.38) NS – – –
BIS-11b Sig 1-tailed
p (2)
Sheffé comparisons sig 1-tailed p
Attention 14.61 (0.56) 16.81 (0.68) 16.52 (0.63) .012 (.097) .026 .042 NS
Motor 19.58 (0.83) 22.91 (1.01) 22.36 (0.92) .011 (.099) .023 .045 NS
Non-planning 23.19 (0.85) 26.67 (1.04) 26.56 (0.96) .006 (.113) .021 .019 NS
Total  57.39 (1.75) 66.38 (2.14) 65.44 (1.96) .001 (.158) .004 .007 NS
Stroop Color Word Test Sig 1-tailed
p (2)
Sheffé comparisons sig 1-tailed p
Color naming
Percent accuracy 94.28 (5.68) 91.59 (10.54) 92.98 (8.02) NS NS NS NS
Omissions 4.53 (5.79) 7.38 (11.22) 6.08 (8.86) NS NS NS NS
Commissions 2.09 (2.31) 2.71 (2.48) 2.35 (2.33) NS NS NS NS
Word reading
Percent accuracy 99.07 (1.81) 97.95 (3.31) 98.37 (2.51) NS NS NS NS
Omissions 0.56 (1.31) 1.04 (2.68) 0.77 (1.61) NS NS NS NS
Commissions 0.38 (0.82) 1.42 (1.95) 1.19 (1.63) .011 (.091) .018 NS NS
Interference
Percent accuracy 96.69 (5.33) 88.88 (14.31) 95.72 (7.06) .003 (.212) .005 NS .019
Omissions 0.79 (1.61) 4.42 (7.96) 1.46 (3.14) .007 (.099) .010 NS .046
Commissions 1.59 (2.86) 3.46 (3.82) 1.58 (2.34) .021 (.075) .037 NS .048
a Fagerstrom Test For Nicotine Dependence.
b Barratt Impulsiveness Scale.
Table 3
Clinical rating scale results.
Variable
Mean (SD)
Healthy controls MJ  (whole Group) Sig 2-tailed p Early MJ  onset (before age 16) Late MJ  onset (age 16 or after) Sig 2-tailed p
HAM-Aa 1.62 (2.30) 1.844 (2.03) NS 1.61 (1.67) 2.09 (2.37) NS
MADRSb 1.45 (1.28) 1.97 (1.64) NS 2.00 (1.52) 1.94 (1.77) NS
YMRSc 0.85 (1.14) 1.53 (2.00) NS 1.29 (1.94) 1.72 (2.08) NS
BDId 1.73 (2.64) 2.52 (3.55) NS 2.05 (3.00) 3.00 (4.04) NS
POMSe
Vigor 20.30 (4.37) 19.27 (4.67) NS 18.91 (3.92) 19.57 (5.31) NS
Anger 2.72 (3.70) 4.59 (4.81) NS 3.65 (3.43) 5.42 (5.71) NS
Confusion 4.31 (3.75) 4.86 (2.74) NS 4.48 (2.41) 5.19 (3.01) NS
Tension 5.17 (4.86) 4.84 (3.51) NS 4.70 (3.17) 4.96 (3.84) NS
Fatigue 3.83 (3.29) 3.86 (2.96) NS 3.39 (2.62) 4.27 (3.22) NS
Depression 3.27 (3.75) 3.45 (4.49) NS 2.26 (2.60) 4.50 (5.51) NS
Total  mood disturbance −1.00 (16.93) 2.33 (16.13) NS −0.43 (11.43) 4.77 (19.27) NS
PANASf
Positive 32.46 (6.10) 33.04 (6.93) NS 31.91 (7.69) 34.04 (6.16) NS
Negative 11.18 (1.98) 12.08 (3.27) NS 11.87 (3.09) 12.27 (3.46) NS
STAIg
Y1 (state) 26.20 (4.05) 27.48 (5.89) NS 27.79 (5.07) 27.24 (6.64) NS
Y2  (trait) 30.20 (7.15) 29.00 (6.67) NS 29.14 (6.01) 28.88 (7.35) NS
a Hamilton Anxiety Scale.
b Montgomery-Asberg Depression Rating Scale.
c Young Mania Rating Scale.
d Beck Depression Inventory.
e Proﬁle of Mood States.
f Positive and Negative Affect Schedule.
g State-Trait Anxiety Inventory.
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Fig. 1. Logarithmic regression analysis: age of onset of MJ  use vs Stroop Interference
commission errors. Within the MJ  smokers, earlier age of onset was signiﬁcantly
associated with poorer performance on the Stroop Interference subtest, includ-
ing  increased commission errors, or incorrect responses (R2 = .076, F(1, 48) = 3.929,
p  = .027).
Table 4
Univariate logarithmic regression analyses of MJ  use demographics and Stroop inter-
ference performance.
Stroop Color Word Test R2 F Sig 1-tailed
Interference percent accuracy
Age of MJ  onset .067 3.433 .035
Smokes/week .108 5.583 .011
Grams/week .239 14.421 <.001
Interference omissions
Age of MJ  onset .041 2.067 NS
Smokes/week .057 2.2793 .051
Grams/week .140 7.470 .005
Interference commissions
Age of MJ  onset .076 3.929 .027
Smokes/week .167 9.237 .002
I
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a
h
H
t
Fig. 2. Stroop (interference-rest/ﬁxation)–(color naming-rest/ﬁxation) fMRI acti-
vation: single-group comparison. Single-group comparisons on the Stroop
Interference condition: HCs (A) demonstrated robust posterior activation in the right
cingulate, while MJ  smokers (B) exhibited more diffuse activation throughout the
cingulate. Within MJ  smokers, the early onset group (C) demonstrated activation in
the  anterior region of the cingulate, adjacent to the genu of the corpus callosum,
T
SGrams/week .288 18.582 <.001
nterestingly, results also indicated that differences between HCs
nd MJ  smokers were primarily attributable to the early onset MJ
mokers who exhibited activation in the left anterior cingulate
djacent to the genu of the corpus callosum. Late onset smokers,
owever, demonstrated an activation pattern more similar to the
C group, with posterior right-hemisphere activation localized to
he right cingulate cortex (Fig. 2).
able 5
troop activation: local maxima for single-group comparisons with cingulate cortex regio
Comparison group
Region
Cluster size (voxels) x 
1-Sample t-tests against null
Healthy controls
Right middle cingulum, BA23 679 12 
All  MJ  smokers
Left anterior cingulum, BA24 62 −4 
Left  posterior cingulum, BA23 47 −10 
Middle frontal gyrus, BA10 62 4 
Right  middle cingulum 69 16 
Right  middle cingulum 11 0 
Left  anterior cingulum, BA32 59 0 
Right  middle cingulum, BA23 15 2 
Left  middle cingulum, BA31 13 −2 
Early  MJ  smokers
Left anterior cingulate, BA32 259 −6 
Late  MJ  smokers
Right middle cingulum, BA31 89 6 whereas late onset smokers (D) exhibited posterior activation in the right cingulate,
more similar to the HC group.
4. Discussion
As hypothesized, MJ  smokers performed signiﬁcantly more
poorly than HCs on the Interference condition of the Stroop Color
Word Test, a frontally mediated task of executive function that
assesses the ability to inhibit inappropriate responses. MJ  smokers
also reported signiﬁcantly higher levels of impulsivity as measured
by the BIS-11. Analyses designed to assess the potential impact of
age of onset of MJ  use revealed that those who initiated regular MJ
use prior to age 16 (early onset) demonstrated signiﬁcantly poorer
performance compared to both HCs and those who  began using MJ
at age 16 or later (late onset). Interestingly, early onset smokers
smoked, on average, nearly twice as often and more than 2.5 times
as much MJ  each week relative to the late MJ  onset group. Regres-
sion analyses also indicated that earlier age of MJ  onset, increased
frequency and magnitude (grams/week) of MJ  use were all indi-
vidually predictive of worse task performance, speciﬁcally, lower
percent accuracy and higher commission errors.
In addition, fMRI analyses revealed that MJ  smokers demon-
strated signiﬁcantly different activation patterns during the Stroop
Interference condition relative to HCs. While the HCs demonstrated
nal of interest (ROI).
y z SPM {t} Voxel p
Uncorrected
−48 33 6.09 <.001
2 30 5.10 <.001
−46 32 4.98 <.001
50 14 4.94 <.001
−39 40 4.71 <.001
−14 31 4.64 <.001
34 22 4.61 <.001
−32 31 3.93 <.001
−32 40 3.83 <.001
50 −2 8.81 <.001
−32 50 6.81 <.001
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 more focal, posterior pattern of activation, suggestive of increased
eural efﬁciency, MJ  smokers exhibited a more diffuse pattern in
he anterior portion of the ROI. Similar to the behavioral results,
hich revealed that performance deﬁcits in the MJ  group were
ore pronounced in the early onset smokers, fMRI analyses also
evealed that functional alterations in the MJ  smokers were pri-
arily driven by the early onset smokers. Relative to the HC group,
ate onset MJ  smokers demonstrated a similar, focal posterior pat-
ern of activation while early onset smokers exhibited a vastly more
nterior pattern, localized to the anterior ACC. These ﬁndings sug-
est that earlier exposure to regular MJ  use may  result in greater
ulnerability to behavioral and functional brain alterations relative
o later exposure.
Data from the current study are consistent with previous work
emonstrating poorer performance of inhibitory tasks in MJ  smok-
rs relative to HCs (Gruber and Yurgelun-Todd, 2005; Thames
t al., 2014) and more speciﬁcally, those which have reported a
igniﬁcant inverse relationship between age of onset of MJ  use
nd cognitive performance. For example, several studies have doc-
mented more pronounced neurocognitive deﬁcits spanning a
ange of domains in those who begin smoking MJ  during adoles-
ence, including attention (Ehrenreich et al., 1999), visual search
Huestegge et al., 2002), IQ (Filbey et al., 2014; Meier et al., 2012;
ope et al., 2003), and executive function (Fontes et al., 2011;
ruber et al., 2012a; Solowij et al., 2012). Results from the cur-
ent study also support and extend previous research, which has
oted functional alterations in MJ  smokers during inhibitory tasks
Battisti et al., 2010; Becker et al., 2010; Behan et al., 2014; Gruber
t al., 2012b).
Analyses revealed that both frequency and magnitude of MJ
se were independently predictive of poorer task performance,
uggesting that increased MJ  use appears to represent a trait char-
cteristic speciﬁc to the early onset MJ  smokers. Consequently,
ndividuals with earlier MJ  onset may  collectively have an “additive
ulnerability” – a relatively immature brain that is suscepti-
le to the impact of MJ  exposure, further compounded by an
ncreased likelihood to engage in higher levels of MJ  use than those
ith later exposure. This combination may  help explain the rel-
tively impaired behavioral performance and altered patterns of
rain activation noted during inhibitory tasks in early MJ  onset
mokers relative to those with later onset. Taken together, study
ndings underscore the importance of independently assessing
ge of ﬁrst regular MJ  use as well as frequency and magnitude
f use.
In the current study, behavioral impulsivity (frequently elevated
n those who use substances) was signiﬁcantly higher within the MJ
roup relative to HCs. Interestingly, however, no between-group
ifferences were between the early and late onset MJ smokers.
onetheless, as higher levels of reported impulsivity and poorer
erformance on inhibitory tasks have been well-documented in
J users (Battisti et al., 2010; Gruber et al., 2012a; Solowij et al.,
012), these characteristics may  reﬂect an important trait to be
argeted for prevention. Prevention efforts must also target youth
t a young age; it is now widely recognized that the brain devel-
ps well into adulthood and that the neural circuitry associated
ith inhibitory control undergoes signiﬁcant development dur-
ng adolescence (Giedd et al., 1999; Casey et al., 2005; Squeglia
t al., 2009), leaving the brain particularly vulnerable during this
ime.
The current study provides a valuable contribution to the ﬁeld
or several reasons. First, results were derived from a relatively
arge sample of well-characterized, chronic MJ  smokers who were
horoughly assessed for frequency, magnitude, and age of onset
f MJ  use. In addition, ﬁndings provide further evidence that
xecutive function impairment in MJ  smokers is accompanied
y observable functional brain alterations, which differ betweenve Neuroscience 16 (2015) 84–92
those with early and late MJ  onset. Taken together, both behavioral
and imaging results suggest that more pronounced difﬁculty with
tasks requiring cognitive control is associated with earlier onset
of MJ  use. These ﬁndings are consistent with reports of altered
brain activation patterns in early vs late MJ  onset smoking groups
during the performance of an inhibitory task (Gruber et al., 2012b);
however, the current study demonstrates differences in task per-
formance between the groups, not previously documented. This
may be the result of increased power given the larger sample sizes
presently included, but may  also be attributable to the fact that
the Stroop Interference condition is considered one of the most
robust measures of inhibitory function, especially when responses
are vocalized, as in the current study (MacLeod, 1991). Further,
while ﬁndings demonstrated differences in task performance
between those with early MJ  onset and HCs, no between-group
task differences were detected between the late MJ  onset and HCs,
suggesting a speciﬁc vulnerability of the early onset group. Given
that the brain undergoes signiﬁcant development during adoles-
cence and emerging adulthood (Casey et al., 2005; Giedd et al.,
1999; Gogtay et al., 2004) and that the frontal cortex is among
the last of the brain regions to mature (Sowell et al., 1999), it is
perhaps not surprising that individuals with earlier exposure to
MJ have difﬁculty with tasks requiring frontal/executive function.
Inconsistent reports of impaired cognitive function in MJ smokers
may  therefore be explained by studies that do not assess age
of MJ  onset independently. Given that individuals with late MJ
onset performed similarly to HCs in the current study, and on
a range of other cognitive measures in previous studies (Fontes
et al., 2011; Gruber et al., 2012a; Pope et al., 2003), it is possible
that including late MJ  onset smokers’ cognitive performance
scores with early onset MJ  smokers’ may  diminish signiﬁcant
results.
4.1. Limitations
While compelling, ﬁndings from the current study must be
interpreted within the context of several limitations. First, while all
subjects were required to abstain from MJ  for a minimum of 12 h,
we cannot exclude the possibility that some smokers may  have
used MJ  within this time frame. It is of note, however, that no sub-
ject appeared altered or intoxicated, and all completed study visits
without difﬁculty. Current methods to ensure subjects abstained
from use have previously been used successfully (Gruber et al.,
2013, 2012a,b, 2011) and as a result, it is likely that the 12-h absti-
nence minimum was  followed. In addition, although the current
study quantiﬁed frequency and magnitude of MJ  use little is known
about the potency of different strains of MJ  used by participants.
While unlikely to impact the current ﬁndings (as individuals from
early and late MJ  groups are recruited from similar geographic
locations and report similar use), future research should exam-
ine the relationship between MJ  potency and cognitive function.
While some studies have utilized self-report estimates of potency
(van der Pol et al., 2013), laboratory analyses of the constituents
of MJ  (i.e., THC, cannabidiol) are likely to provide insight into
the differential effects of potency levels as well as the impact of
speciﬁc constituents of MJ.  Further, subjects in the current study
spanned a wide age range (17–48) in comparison to other investi-
gations. It is of note, however, that the groups were well-matched
for age, and study ﬁndings are likely generalizable to a larger
population.
Future research should clarify several areas regarding adoles-
cent MJ  use and the brain. First, while results demonstrated that
age of onset of use was  an important predictor of impairment, fre-
quency and magnitude of MJ  use also contributed signiﬁcantly to
study ﬁndings. Therefore, higher frequency and magnitude of MJ
use, also noted in previous studies (Gruber et al., 2012a, 2013),
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ay  be inextricably linked to earlier onset of MJ  use, an important
ublic health issue bearing further investigation. Additional studies
hould explore this relationship, as both increased frequency and
agnitude of MJ  use predicted worse cognitive performance to a
reater degree than age of onset of MJ  use. It is also important to
xamine how age of onset impacts executive function and func-
ional brain changes in a group of occasional MJ  smokers. Notably,
he current study examined only chronic MJ  smokers, the major-
ty of whom reported smoking multiple times per day, and who
ad no history of other drug use or other Axis I pathology. Finally,
Q scores were signiﬁcantly higher than average across all study
roups, a ﬁnding reported in several previous studies including
J  smokers using a cross-sectional design (Pope and Yurgelun-
odd, 1996; Pope et al., 2001; Gruber and Yurgelun-Todd, 2005;
ruber et al., 2012a,b; Thames et al., 2014). Above average IQ
cores in the current sample may  reﬂect the geographic region used
or recruitment, as the Boston area is surrounded by numerous
niversities, research centers, and hospitals. In addition, partici-
ants completed measures of estimated IQ using well-validated,
ormed assessments, commonly used for screening purposes but
hich may  be more vulnerable to overestimating full scale IQ
elative to comprehensive IQ assessments (e.g., WAIS-IV). Interest-
ngly, despite signiﬁcantly higher than average IQ scores across the
roups and no between-group differences noted in IQ, MJ  smok-
rs overall demonstrated reduced cognitive performance on tasks
equiring cognitive control/inhibitory function. This ﬁnding, con-
istent with previous investigations (Fontes et al., 2011; Gruber
t al., 2012a), suggests that MJ  use may  differentially impact indi-
idual cognitive domains, with general IQ and other measures being
elatively spared, while frontal/executive measures are subject to
mpairment. The current results, therefore, may not be generaliz-
ble to less frequent MJ  smokers, those with comorbid psychiatric
r substance use disorders, or those who exhibit lower IQ
cores.
While some investigations have assessed MJ smokers after brief
eriods of abstinence and reported between group differences rel-
tive to non-MJ smokers (Bolla et al., 2002, 2005; Hanson et al.,
010; Jacobus et al., 2014; Tapert et al., 2007), the question remains
hether cognitive deﬁcits and altered brain function may  be par-
ially or fully remediated after longer abstinence periods. Studies
f former MJ  smokers are needed to extend research and provide
rucial information to shape prevention messages and public pol-
cy. Finally, as the current investigation utilized a cross-sectional
esign, it is not possible to determine “cause” from “effect.” Despite
he strong association demonstrated between MJ  use, reduced
ognitive performance and altered patterns of brain activation,
t is not possible to ascertain if these differences preceded MJ
se, resulted from MJ  use, or represent a combination of factors.
ongitudinal studies designed to assess individuals prior to MJ
se and follow them over time are needed to address this issue.
hese studies will also provide an opportunity to independently
ssess the impact of age of onset of MJ  use from current MJ  use
atterns.
. Conclusions
Given growing evidence suggesting that earlier onset of MJ  use
s related to increased cognitive deﬁcits and neurobiologic alter-
tions, the trend of increased MJ  use among emerging adults and
he increasing number of states with recreational and medical MJ
vailable, it is critical to educate the nation regarding the poten-
ially negative impact of MJ.  As states consider legislature for both
ecreational and medical MJ  use, it is imperative to determine safe
uidelines regarding the impact of MJ  on the brain, particularly
uring critical periods of neurodevelopment.ve Neuroscience 16 (2015) 84–92 91
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